7W5-48777-58470
4 vaccinations
3 coded responses
38 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 801 / CO
- Registered
- 2020-12-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
GMF-11832-81176
Child or adolescent in my care · Male · 2021-11-06
BGP-60849-65569
Child or adolescent in my care · Female · 2021-11-06
JN2-58814-43029
Child or adolescent in my care · Female · 2022-06-22
U7G-33065-54792
Child or adolescent in my care · Female · 2022-06-22
Timeline
-
2020-12-19
Registered in v-safe
-
2020-12-19
Dose 1 — Pfizer-BioNTech
-
2020-12-19
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2020-12-20
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2020-12-21
- 2020-12-22
- 2020-12-27
-
2021-01-02
Survey response — day 14, dose 1MedDRA: Exercise tolerance decreased, Fatigue, Pregnancy — Feeling: GoodFree text: Fatigue and decreased exercise tolerance (but I am pregnant so not sure if it is at all related to the vaccine or if it's just pregnancy).MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-09
Dose 2 — Pfizer-BioNTech
-
2021-01-09
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-01-10
Survey response — days 1–6 daily, dose 2MedDRA: Pruritus — Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: PruritisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-10
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-23
- 2021-02-01
- 2021-02-06
- 2021-02-08
- 2021-02-13
- 2021-02-20
- 2021-04-10
- 2021-07-10
-
2021-08-16
Dose 3 — Pfizer-BioNTech
- 2021-09-28
- 2021-11-15
- 2022-02-14
- 2022-08-16
-
2022-09-06
Dose 4 — Moderna
-
2022-09-07
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-09-08
- 2022-09-09
- 2022-09-10
- 2022-09-11
- 2022-09-13
- 2022-09-20
- 2022-09-28
- 2022-10-04
- 2022-10-13
- 2022-10-20
-
2022-12-06
Survey response — 3 months, dose 4MedDRA: Influenza — Feeling: Good · Be unable to do your normal daily activitiesFree text: InfluenzaMedDRA releases: 2024-11 · check-in free text available
- 2023-03-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech | |
| 3 | 2021-08-16 | Pfizer-BioNTech | No |
| 4 | 2022-09-06 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-10 | Unsuccessful |
Free text
Release 1 — day 14, dose 1
Symptoms: Fatigue and decreased exercise tolerance (but I am pregnant so not sure if it is at all related to the vaccine or if it's just pregnancy).
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Pruritis
Release 12 — 3 months, dose 4
Symptoms: Influenza
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Exercise tolerance decreased | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Maternal exposure during pregnancy | ○ | ○ | ○ |
| SD | Pregnancy | ✓ | ✓ | ✓ |
| SRO | Pruritus | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release